Company Search:
Advanced Search
Sponsored Links
Medivation, Inc. Company Snapshot
Medivation, Inc. operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Medivation with three other companies in this sector in the United States: Biomarin Pharmaceutical Inc (2015 sales of $889.90 million of which 34% was Naglazyme), Akorn, Inc. ($985.08 million of which 94% was Prescription Pharmaceuticals), and Indivior Plc ($1.01 billion of which 100% was Buprenorphine Based Drugs).

Sales Analysis. Medivation reported sales of $943.26 million for the year ending December of 2015. This represents an increase of 32.8% versus 2014, when the company's sales were $710.49 million. This was the fourth straight year of sales growth at Medivation.
  Stock Performance Chart for Medivation, Inc.
  Stock Data: Recent Stock Performance:
  Current Price (9/23/2016): 81.42
(Figures in U.S. Dollars)
1 Week 0.7%   13 Weeks 1.3%  
4 Weeks 43.0%   52 Weeks 95.5%  
Medivation, Inc. Key Data:
  Ticker: MDVN Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 943,258,000
(Year Ending Jan 2016).
Employees: 628
  Currency: U.S. Dollars Market Cap: 13,509,912,637
  Fiscal Yr Ends: December Shares Outstanding: 165,928,674
  Share Type: Common Closely Held Shares: 2,203,222
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.